Trial Profile
Sympathetic activation, microcirculation, haemostasis and inflammation in diabetic and non-diabetic kidney disease: disease modification by vitamin D receptor activation.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2012
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 26 Aug 2011 New trial record